St. Elisabeth-Krankenhaus Leipzig

Leipzig 04277

1 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Carcinoma, Non-Small-Cell Lung, Diabetes Mellitus, Type 2

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%) — Completed